TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 78 filers reported holding TRINITY BIOTECH PLC in Q1 2016. The put-call ratio across all filers is 5.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $14,000 | +27.3% | 5,200 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $11,000 | -45.0% | 5,200 | 0.0% | 0.01% | -30.0% |
| Q3 2018 | $20,000 | -23.1% | 5,200 | 0.0% | 0.01% | -33.3% |
| Q1 2018 | $26,000 | 0.0% | 5,200 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $26,000 | -10.3% | 5,200 | 0.0% | 0.02% | -11.8% |
| Q3 2017 | $29,000 | -6.5% | 5,200 | 0.0% | 0.02% | -15.0% |
| Q2 2017 | $31,000 | -99.9% | 5,200 | 0.0% | 0.02% | +5.3% |
| Q1 2017 | $30,992,000 | -13.9% | 5,200 | 0.0% | 0.02% | -17.4% |
| Q4 2016 | $35,984,000 | -47.7% | 5,200 | 0.0% | 0.02% | -50.0% |
| Q3 2016 | $68,744,000 | +16.6% | 5,200 | 0.0% | 0.05% | +21.1% |
| Q2 2016 | $58,968,000 | -2.7% | 5,200 | 0.0% | 0.04% | -15.6% |
| Q1 2016 | $60,632,000 | +99296.7% | 5,200 | 0.0% | 0.04% | +12.5% |
| Q4 2015 | $61,000 | – | 5,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |